OxyContin maker Purdue Pharma LP steered up to US$13 billion in profits to the company’s controlling Sackler family, according to U.S. states opposing efforts to halt lawsuits alleging the company and its owners helped fuel the U.S. opioid epidemic.
Sacklers reaped up to US$13 billion from OxyContin maker, US states say
